Tilray, Inc. and Authentic Brands Group announced that they have signed a long-term revenue sharing agreement to market and distribute a portfolio of consumer cannabis products within ABG’s brand portfolio in jurisdictions where regulations permit. Under the terms of the agreement: The parties will leverage ABG’s portfolio of brands to develop, market and distribute consumer cannabis products across the world, as and where legal, with an immediate focus on opportunities, including CBD, in Canada and the U.S. subject to applicable and brand appropriate regulations. Tilray will be the preferred supplier of active cannabinoid ingredients for such products. Tilray will initially pay to ABG USD 100 million and up to USD 250 million in cash and stock, subject to the achievement of certain commercial and/or regulatory milestones. Tilray will have the right to receive up to 49% of the net revenue from cannabis products bearing ABG brands, with a guaranteed minimum payment of up to USD 10 million annually for 10 years, subject to certain commercial and/or regulatory milestones. Through this agreement, ABG and Tilray join forces at the intersection of science and brand to connect consumers with innovative health and wellness products suited to their many lifestyle needs.